Health New Bispecific Antibody Approved for Tough-to-Treat Lymphoma Eli Pacheco Jun 17, 2023 0 The FDA has granted accelerated approval to glofitamab (Columvi) for adults…
Health Immunotherapy Combo Shows Promise in Tough-to-Treat, Early Bladder Cancer Eli Pacheco May 26, 2023 0 Preliminary findings presented at the American Urological Association (AUA) annual meeting…
Health Ketamine Beats Shock Therapy in Easing Tough-to-Treat Depression Eli Pacheco May 25, 2023 0 Cara Murez THURSDAY, May 25, 2023 (HealthDay News) -- Ketamine may be an alternative to shock treatment for people with treatment-resistant…
Health Adding Abilify Eased Tough-to-Treat Depression in Seniors Eli Pacheco Mar 4, 2023 0 Adding another antidepressant to the mix was more helpful than switching agents in older…
Health FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer Eli Pacheco Dec 20, 2022 0 Cara Murez MONDAY, Dec. 19, 2022 (HealthDay News) -- Patients with a high-risk bladder cancer now have a new option to treat it.The U.S. Food and Drug…
Health Combo Drug May Fight Tough-to-Treat UTIs Eli Pacheco Nov 2, 2022 0 Dennis Thompson TUESDAY, Nov. 1, 2022 (HealthDay News) -- Doctors could soon have access to a new weapon in the ongoing battle against…
Health Novel Siderophore Cephalosporin Nets Promising Results in Tough-to-Treat CRAB Eli Pacheco Oct 24, 2022 0 WASHINGTON – Cefiderocol (Fetroja) may be a viable targeted-therapy option in critically ill patients with carbapenem-resistant…
Health Novel genetic experiment shrinks tough-to-treat cancer Eli Pacheco Jun 2, 2022 0 By LAURAN NEERGAARD - AP Medical Writer In a novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after…
Health Novel ADC Promising in Tough-to-Treat Ovarian Cancer Eli Pacheco Mar 20, 2022 0 PHOENIX -- Mirvetuximab soravtansine monotherapy demonstrated anti-tumor activity in previously treated patients with folate…
Health Dupilumab May Help in Tough-to-Treat Chronic Spontaneous Urticaria Eli Pacheco Feb 28, 2022 0 PHOENIX -- Patients who received add-on dupilumab (Dupixent) treatment for chronic spontaneous urticaria (CSU) had reduced symptoms…